Why is Eiko Lifescience falling/rising?

As of 10-Jul, Eiko Lifesciences Ltd is experiencing a decline in its stock price, currently at Rs 56.75, which represents a decrease of Rs 2.75 or 4.62%. The stock has been underperforming, having fallen consecutively for the last two days with a total drop of 6.03%. Today's trading saw the stock reach an intraday high of Rs 60.99 and a low of Rs 56, indicating significant volatility. Additionally, the stock has underperformed its sector by 4.75% today and has a negative return of 12.42% over the past week, while showing a modest gain of 10.62% over the past month. Despite a recent increase in promoter confidence, with a 4.96% rise in their stake, the company faces challenges such as weak long-term fundamentals, reflected in a low average Return on Equity (ROE) of 2.82% and a significant drop in net sales.
In the broader market context, the Sensex has remained relatively stable, with only a slight decline of 0.06% over the past week. Eiko Lifesciences' recent performance contrasts sharply with this benchmark, particularly in the short term, where it has significantly lagged behind. While the stock has shown some positive movement over a longer period, such as a 20.87% increase over the past three years, its year-to-date performance is concerning, with a decline of 9.55% compared to the Sensex's gain of 6.46%. This disparity highlights the stock's struggles in the current market environment, compounded by falling investor participation and liquidity issues.